Mannkind (MNKD) Operating Expenses (2010 - 2026)
Mannkind's (MNKD) quarterly Operating Expenses came in at $91.8 million in Q1 2026, up 63.82% year-on-year from $56.1 million in Q1 2025, and down 23.24% on a QoQ basis from $119.6 million in Q4 2025.
Mannkind (MNKD) Operating Expenses (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Operating Expenses data on file, last reported at $91.8 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 63.82% year-over-year to $91.8 million in Q1 2026; TTM through Mar 2026 was $345.9 million, a 57.65% increase from a year earlier, with the FY2025 full-year figure at $310.2 million, up 45.67% from the prior year.
- Operating Expenses for Q1 2026 stood at $91.8 million, down from $119.6 million in the prior quarter.
- Over the last five years, Operating Expenses for MNKD reached as high as $119.6 million in Q4 2025 and fell as low as $33.2 million in Q1 2022.
- Historically, Operating Expenses has averaged $57.0 million across 5 years, with a median of $50.3 million in 2024.
- Across the five-year window, Operating Expenses fell 0.66% in 2024 and soared 137.95% in 2025, its largest moves.
- Year by year, Operating Expenses stood at $48.8 million in 2022, then gained by 3.61% to $50.6 million in 2023, then declined by 0.66% to $50.3 million in 2024, then surged by 137.95% to $119.6 million in 2025, then decreased by 23.24% to $91.8 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $91.8 million in Q1 2026, $119.6 million in Q4 2025, and $63.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | 91.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.84 Mn |
| Dec 31, 2025 | 119.64 Mn |
| Sep 30, 2025 | 63.23 Mn |
| Jun 30, 2025 | 71.23 Mn |
| Mar 31, 2025 | 56.06 Mn |
| Dec 31, 2024 | 50.28 Mn |
| Sep 30, 2024 | 57.32 Mn |
| Jun 30, 2024 | 55.78 Mn |
| Mar 31, 2024 | 49.54 Mn |
| Dec 31, 2023 | 50.61 Mn |
| Sep 30, 2023 | 46.16 Mn |
| Jun 30, 2023 | 46.89 Mn |
| Mar 31, 2023 | 46.62 Mn |
| Dec 31, 2022 | 48.85 Mn |
| Sep 30, 2022 | 42.44 Mn |
| Jun 30, 2022 | 39.35 Mn |
| Mar 31, 2022 | 33.25 Mn |
| Dec 31, 2021 | 36.48 Mn |
| Sep 30, 2021 | 28.80 Mn |
| Jun 30, 2021 | 33.55 Mn |